سعر ريالتريس سبراي للأنف 120 جرعة 2024

Metered nasal spray (120 sprays) combining the H1 antihistamine olopatadine and the corticosteroid mometasone furoate (Glenmark), for seasonal allergic rhinitis symptoms.

• Treatment of symptoms of seasonal allergic rhinitis in adults and children 6 years and older.Population: Adults and children 6 years and olderDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions: dysgeusia, epistaxis, nasal discomfort and headache (patients 12 years and older).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Local nasal effects: epistaxis, nasal ulceration, nasal septal perforation, impaired wound healing and Candida infection; avoid after recent nasal ulcers, surgery or trauma until healed.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Somnolence may occur; caution with driving or operating machinery, and avoid alcohol and other CNS depressants.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Glaucoma and cataracts: consider ophthalmological examination with changes in vision or a history of raised intraocular pressure, glaucoma or cataracts.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Alcohol and other CNS depressantsConcomitant use may further decrease alertness and impair CNS performance; avoid.DailyMed (U.S. National Library of Medicine)
• Strong CYP3A4 inhibitors (e.g. ritonavir, ketoconazole)May increase systemic mometasone exposure and the risk of corticosteroid adverse effects; use with caution.DailyMed (U.S. National Library of Medicine)

• US label: no available data on RYALTRIS or mometasone furoate use in pregnant women to evaluate drug-associated risk; postmarketing experience with antihistamines of similar mechanism has not identified a drug-associated risk, but there are no human data specific to olopatadine.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• US label: no data on olopatadine or mometasone furoate in human milk or effects on the breastfed child or milk production; mometasone plasma levels after nasal doses are low, so milk levels are likely low.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.